Keranova has raised 24 million euros in a second round of financing to support development of its automated robotized procedures for cataract surgery, according to a press release.
The funding round was led by Mérieux Equity Partners and Supernova Invest, with participation from Financière Arbevel, Tourrette Investissement and other international partners, the release said.
Keranova’s ultra-fast robotized laser treats cataracts and in the future may treat myopia and astigmatism as well.
“We are extremely proud to have succeeded in producing such a revolutionary machine
Uncategorized